Immucell (ICCC) Current Leases (2020 - 2026)

Immucell (ICCC) has reported Current Leases for 7 consecutive years, with $121858.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Current Leases fell 62.24% year-over-year to $121858.0; the trailing twelve-month figure through Jun 2026 stood at $121858.0 (down 62.24% YoY), and the FY2025 full-year result was $85489.0, down 80.21% from the prior year.
• Current Leases grew to $121858.0 in Q2 2026 per ICCC's latest filing, from $85489.0 in the prior quarter.
• Across five years, Current Leases topped out at $644276.0 in Q4 2023 and bottomed at $22920.0 in Q3 2022.
• Historically, Current Leases has averaged $241971.9 across 5 years, with a median of $112092.0 in 2022.
• The sharpest annual moves came in 2023 and 2025: Current Leases surged 1928.32% in 2023, then sank 82.9% in 2025.
• Over 5 years, Current Leases stood at $31764.0 in 2022, then soared by 1928.32% to $644276.0 in 2023, then plunged by 32.94% to $432072.0 in 2024, then tumbled by 80.21% to $85489.0 in 2025, then soared by 42.54% to $121858.0 in 2026.
• According to Business Quant data, Current Leases over the past three periods registered $121858.0, $85489.0, and $82442.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.